A high-profile artificial intelligence startup founder has admitted to participating in an extensive insider trading operation that exploited confidential information about major corporate transactions, court documents revealed this week. Arya Bolurfrushan, who leads the Abu Dhabi-headquartered AppliedAI and previously worked as a banker at Goldman Sachs, entered his guilty plea in June 2025 following negotiations with federal prosecutors in Boston. The admission represents a significant development in a sprawling investigation that has ensnared dozens of individuals across major international law firms and financial markets, exposing vulnerabilities in how privileged deal information is protected within prestigious legal institutions.
The case centres on a scheme where lawyers employed at leading law firms systematically provided Bolurfrushan with non-public details about pending mergers and acquisitions that their employers were advising on, in exchange for a share of the profits he made from trading on these tips. The arrangement involved Nicolo Nourafchan, an attorney who worked across three major firms including Sidley Austin, Latham & Watkins, and Goodwin Procter, and Robert Yadgarov, a personal injury lawyer. Prosecutors allege that Nourafchan and Yadgarov served as the primary conduit for passing sensitive information to Bolurfrushan, who then executed trades designed to capitalise on knowledge that would not become public until official announcements were made.
Bolurfrushan's connection to the legal operatives emerged through family connections, according to authorities. He was recruited into the scheme in 2023 while based in Dubai, marking the beginning of his involvement in what prosecutors characterise as a coordinated effort to exploit the inherent information asymmetries that exist within law firms handling major transactions. The scheme operated with apparent sophistication, leveraging the trust and access that lawyers possessed to access confidential deal documentation. The very nature of legal work on mergers and acquisitions—requiring attorneys to review sensitive corporate information weeks or months before public disclosure—created opportunities for abuse that the conspirators systematically exploited.
Court records unsealed on Monday detailed one particularly significant transaction that formed the basis of charges against Bolurfrushan. In September 2023, while working as an associate at Goodwin Procter, Nourafchan accessed internal documents relating to the acquisition of Orchard Therapeutics by Japanese pharmaceutical company Kyowa Kirin Co Ltd, a deal his firm was advising on but to which he had not been assigned. Rather than maintaining confidentiality, Nourafchan tipped off Bolurfrushan about the impending merger. Bolurfrushan then purchased securities in Orchard ahead of the public announcement, ultimately generating trading profits of approximately $950,000. From these gains, he distributed roughly $60,000 to Nourafchan and Yadgarov as compensation for their role in providing the inside information.
The conspiracy continued into mid-2024 with additional fraudulent transactions. Bolurfrushan engaged in further insider trading based on confidential information regarding investment firm Sixth Street's planned $5.1 billion acquisition of insurance company Enstar. This subsequent violation suggests the scheme had become entrenched in the conspirators' operational framework, with each successful trade emboldening them to undertake additional illegal transactions. The pattern indicates not merely isolated misconduct but rather an organised system designed to generate repeated profits through repeated violations of securities law.
As part of his guilty plea agreement, Bolurfrushan committed to forfeit $954,496 derived directly from his illegal trading activities. Federal prosecutors have recommended a two-year prison sentence as appropriate punishment for his conduct. His cooperation with authorities has positioned him as a cooperative witness in the broader investigation, a role reflected in the nature of his plea arrangement. Notably, his lawyer Jordan Estes at the prominent firm Gibson, Dunn & Crutcher declined to comment on the case, maintaining client confidentiality while the legal proceedings continue.
The broader investigation has expanded significantly beyond Bolurfrushan's involvement. Nine other individuals previously entered guilty pleas in confidential proceedings before prosecutors publicly announced charges against a larger group of approximately 30 people. Among those continuing to contest the allegations are Nourafchan and Yadgarov, who have pleaded not guilty to securities fraud and related charges. Their forthcoming trial will likely reveal further details about the mechanics of how information circulated between law firms and trading operations, potentially exposing systemic vulnerabilities in how elite legal institutions safeguard client confidences.
The United States Securities and Exchange Commission has pursued parallel civil enforcement action against Bolurfrushan, with the agency settling its claims against him on the same day the court documents were unsealed. The dual criminal and civil approach reflects the severity with which American regulators treat insider trading violations, particularly when they involve the breach of attorney-client privilege and fiduciary duties. The SEC's involvement ensures that beyond criminal penalties, Bolurfrushan faces potential civil sanctions and permanent restrictions on his involvement in securities markets.
This case illuminates broader concerns about information security within the legal profession during an era when artificial intelligence and data analytics make it increasingly possible to detect unusual trading patterns and correlate them with legal developments. The Boston prosecution demonstrates that even highly sophisticated market participants cannot indefinitely exploit confidential legal information without triggering regulatory scrutiny. For Malaysian investors and financial professionals, the case serves as a cautionary example of how participation in insider trading schemes carries severe consequences under American law, including potential imprisonment and substantial financial forfeiture, irrespective of one's status as a prominent technology entrepreneur or foreign national.
